This HTML5 document contains 253 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q65383876
rdf:type
wikibase:Item
schema:description
клінічне випробування clinical trial ensayu clínicu klinisch onderzoek
rdfs:label
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
skos:prefLabel
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
schema:name
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
p:P1476
wds:Q65383876-3D1375F8-D1C6-4FFA-A0E5-9158CD289BDE
wdt:P1476
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
p:P582
wds:Q65383876-847368AD-6E99-4E84-8CC5-990777B4A3FC
wdt:P582
2016-09-30T00:00:00Z
p:P31
wds:Q65383876-2CABFFAB-27F0-400E-AB98-00EADF85A4CB
wdt:P31
wd:Q30612
p:P580
wds:Q65383876-0E726591-D967-467A-84FA-721CAA30681C
wdt:P580
2007-11-02T00:00:00Z
p:P17
wds:Q65383876-22FAFE20-D325-4D3E-8579-CC2C92CAD025 wds:Q65383876-B3B42B74-958C-4C5D-9C5C-D6B5E518F3C1 wds:Q65383876-D65F3408-551F-4599-9ED3-33CD9A3AD67F
wdt:P17
wd:Q419 wd:Q30 wd:Q258
p:P6153
wds:Q65383876-A363942D-EF27-4172-9DEB-A881DF9A8112 wds:Q65383876-A6EEB560-BDB9-4CD2-8252-B8677F91B7D2 wds:Q65383876-A815C007-038F-45C4-B3EF-F0218E0A8AC2 wds:Q65383876-AAED513E-443B-4019-8B4A-9AB56722257A wds:Q65383876-954BB7E5-D670-4009-9738-B0200850B46E wds:Q65383876-9AC33928-CE2E-4B90-BB0B-207A03244829 wds:Q65383876-9BDE7A2B-944D-4AC5-AF0E-C246E28F16BE wds:Q65383876-A21C45E1-5B51-4B50-88D0-69D28A7815CE wds:Q65383876-85075436-EE0F-4D1E-91A1-A57DEED18350 wds:Q65383876-8F48E2BA-41EA-44EB-9F64-05DBCD8CCD8E wds:Q65383876-90D12F75-2CE4-4A70-88C1-EAC4F9664DBA wds:Q65383876-75CD294D-4E35-468B-8E43-33AF832EE04A wds:Q65383876-7C29E7E3-DB45-4ACB-B28D-5D6E8807A0FC wds:Q65383876-7C3B500C-F103-48E5-B702-EF5153D278D3 wds:Q65383876-8193520B-E5E9-4885-9D5E-EF45E520D401 wds:Q65383876-C5B74870-C25C-487B-AA8B-CEE0BC1263E7 wds:Q65383876-C8611877-F473-4F3F-9517-74EEE4F4C44D wds:Q65383876-C9A2AEB6-AC7A-4147-8410-EDDE436DEF6D wds:Q65383876-CB797333-71D3-4370-9B49-A1E987F6295D wds:Q65383876-BD227CD6-0CC1-4594-90B0-7FAECEE0620C wds:Q65383876-BD51C43F-3D4F-41DC-81E5-23C12EAE3006 wds:Q65383876-C1175508-5FC9-4DD0-B0D3-C106D374DC03 wds:Q65383876-C198BA28-9B5F-494A-8DF7-F99CB24D6304 wds:Q65383876-B4DB7AA5-ABBA-4D63-AEAF-4040C1C9F71F wds:Q65383876-B61D4739-4FC2-4D57-BE87-0878759573A2 wds:Q65383876-B6D9E937-F25C-4693-B24B-D7E95B2D779D wds:Q65383876-ABDD529D-560F-4D0E-A683-438DC5F78A88 wds:Q65383876-AE9636D6-0F13-4EFE-A32F-9688FD5B404A wds:Q65383876-B2DE835D-0892-4FDB-A754-C5CB0A1FCE7A wds:Q65383876-E3E165AD-6139-49C5-B649-398BE6C28DE0 wds:Q65383876-E7C48309-657E-4480-9A61-3877ED796121 wds:Q65383876-E7FC7B83-36F6-4035-A923-A957E81FB902 wds:Q65383876-EB9923E5-8805-40CC-B82D-B1065DAAF900 wds:Q65383876-DFA3EF9F-8938-4B91-BB5E-24235A31B935 wds:Q65383876-E0520685-5C99-4D83-B841-79D1C8502F0C wds:Q65383876-E25043EC-F368-44B2-AC1D-8228AB8CF20D wds:Q65383876-E37010F1-6D57-4198-9A9E-AD8720B7DA38 wds:Q65383876-D80C364C-A230-4995-ABC1-0753A3A57909 wds:Q65383876-DAAE7774-28BA-47BB-9CFB-CCCED358EE54 wds:Q65383876-DACC1449-7490-4122-8DB3-F953E0E49E01 wds:Q65383876-DEFB8959-48EE-4AAC-8039-174664DC41B9 wds:Q65383876-CBCAA44E-EA0D-4BD1-BD38-177B2AD07DF7 wds:Q65383876-CE451009-B547-4C43-BF1E-1286EFD4664C wds:Q65383876-D2EC923F-C766-4101-9583-5DA445872B71 wds:Q65383876-FBD260B8-E142-4062-BDE2-3709B1A09FA7 wds:Q65383876-FC7055B8-0381-4157-8711-3EF0A46CF2C2 wds:Q65383876-FCABA229-69BD-447C-A711-03645C36A308 wds:Q65383876-FDB101EA-B00F-4780-A2D0-C1EFB468C369 wds:Q65383876-F4D07978-06BB-498D-BC00-5673088F94E7 wds:Q65383876-F9A11591-8742-4225-A258-A74E76FBE8CE wds:Q65383876-FB394A21-668F-4145-943B-5CBAE9DCA577 wds:Q65383876-F2DA9647-4C9D-42F6-8CB7-751083D1097C wds:Q65383876-F347EF9E-F64D-444A-A861-6A100E908B9D wds:Q65383876-F3A8133E-D562-4A86-A5AE-C1D4481969E7 wds:Q65383876-F47A8D75-1DE8-458F-8DBC-7601DF2CEE41 wds:Q65383876-EC86C0E3-C2AE-495C-95C3-E4CF3B55E9B1 wds:Q65383876-EDA60B8E-D67F-4802-9C30-7BF27F50E890 wds:Q65383876-0FD4C4E6-F900-4565-8B3B-A58E4728A56E wds:Q65383876-143D8571-4BCB-4B5B-A8AA-A4D6910A5BED wds:Q65383876-151E91DB-043D-44D8-B6FF-DF0F1C9C7760 wds:Q65383876-07F799B1-A1DC-4580-ACE8-3B598C0D41AB wds:Q65383876-08305BBA-5AD6-4BDF-B912-9A5B7B036B6E wds:Q65383876-0D34BA77-02D6-4B9B-ABC8-90848ECBC7BC wds:Q65383876-2C1DE62C-8178-4051-A021-555246739C77 wds:Q65383876-314A714E-E96B-460C-A522-BD4A81AC1B5D wds:Q65383876-319945BE-6FB8-42B1-817A-0619DE2C1C76 wds:Q65383876-246DA15A-4C22-4F16-AD27-1EDD76F5C49F wds:Q65383876-280AC268-18E7-47F4-A032-EB6FC5299FC9 wds:Q65383876-2A762AFD-B404-4125-BA40-F0BFE7540660 wds:Q65383876-2B9D4232-8F0C-4E5D-AB6F-0FCC92698B74 wds:Q65383876-1F5723BE-A393-4795-B844-703BD51A3346 wds:Q65383876-226E7188-FD8A-493D-BA14-7AB2519DE0E9 wds:Q65383876-167987B0-06A7-400A-BF33-14863810D087 wds:Q65383876-18619183-F981-4FDA-B06E-87718EEA55A7 wds:Q65383876-1C2C6187-C1D9-4721-9987-6F491BCBC48A wds:Q65383876-50C26D85-1BA2-4474-B3D8-FA6494DEABD3 wds:Q65383876-53D5A816-F7E5-4063-B14B-70E87BF0908A wds:Q65383876-53DFECEB-DFB4-4D36-829E-591FF3334D7C wds:Q65383876-54B44091-0C89-4CE8-BCA6-D03ED3E39A14 wds:Q65383876-4D166B0C-2F3F-43F6-AA7A-45D16A867508 wds:Q65383876-5056B3E3-1E66-41CF-9F8F-941B9D532E19 wds:Q65383876-3D8750A2-0C5B-4AB6-AE94-73C2F406C39B wds:Q65383876-463C50B1-C66B-4741-90F8-56607FB4A797 wds:Q65383876-31EF9EFB-9F69-4A6C-A76B-53FF42262E5D wds:Q65383876-346DF617-8A92-4CF0-A4E7-2D7629908705 wds:Q65383876-39E2B8FF-2959-49BC-9153-75E74B9CB83D wds:Q65383876-3B7D213E-7E63-41FD-9A9C-A241D71975EF wds:Q65383876-72F6D783-7914-4CB6-9988-094E4E284448 wds:Q65383876-73FF2773-F8AA-49D0-B094-C8BB4C45B6AA wds:Q65383876-7427E267-4875-4EF2-80A2-F21D87F2BF2B wds:Q65383876-695781D5-44B4-4696-99FD-EC271D0E72D1 wds:Q65383876-6D35116B-7257-4C78-99C4-A87E13AFA99C wds:Q65383876-6DE7A6B4-1B15-46E7-9010-0B3B3B5956C4 wds:Q65383876-6200D061-7097-4E0E-80A5-41D187627B4B wds:Q65383876-63681E4A-CD96-4C0F-83C4-3240D5A3ADEC wds:Q65383876-63F05AB8-5296-453E-85CA-4425EA778F75 wds:Q65383876-65F2856C-A0B9-4169-883E-D8D883C5C8B2 wds:Q65383876-5D384574-86FA-4F8A-BDB9-594290177D64 wds:Q65383876-611BBA9A-1EA8-420A-88D0-C744C81E46A4 wds:Q65383876-61BCC701-DED1-4D4A-A01C-5FFB3B9B3061 wds:Q65383876-FDB5A848-2267-42E3-BD53-981A7D30644D wds:Q65383876-FEEFB075-020A-4D0F-8D76-AC681C58D7DD
wdt:P6153
wd:Q309350 wd:Q22033932 wd:Q30270451 wd:Q30280592 wd:Q115376 wd:Q1277776 wd:Q192334 wd:Q6878595 wd:Q6806287 wd:Q6914126 wd:Q4980899 wd:Q333886 wd:Q1535116 wd:Q6806451 wd:Q6031854 wd:Q4936104 wd:Q4686887 wd:Q309331 wd:Q30254340 wd:Q6735870 wd:Q6550756 wd:Q7851547 wd:Q5600442 wd:Q6694611 wd:Q7654755 wd:Q5330270 wd:Q5547686 wd:Q4731305 wd:Q30279875 wd:Q5378128 wd:Q30280920 wd:Q1150105 wd:Q7722703 wd:Q4897536 wd:Q16996992 wd:Q5714832 wd:Q5476635 wd:Q1159198 wd:Q30254232 wd:Q30280351 wd:Q30289179 wd:Q492318 wd:Q30281132 wd:Q738258 wd:Q969850 wd:Q30280597 wd:Q499451 wd:Q193727 wd:Q149990 wd:Q235034 wd:Q282097 wd:Q1130172 wd:Q6483178 wd:Q30258334 wd:Q5758843 wd:Q770544 wd:Q7370121 wd:Q2900977 wd:Q7896014 wd:Q4874851 wd:Q30253539 wd:Q392667 wd:Q7971940 wd:Q7972509 wd:Q49117 wd:Q49110 wd:Q7401016 wd:Q849751 wd:Q1476505 wd:Q50039515 wd:Q7016630 wd:Q50036553 wd:Q30288257 wd:Q3145247 wd:Q5592136 wd:Q131252 wd:Q1048851 wd:Q30280436 wd:Q30281118 wd:Q7331030 wd:Q30280192 wd:Q14716149 wd:Q7604005 wd:Q6936903 wd:Q2078787 wd:Q1808012 wd:Q5214961 wd:Q7320925 wd:Q29052 wd:Q30254005 wd:Q457281 wd:Q87932226 wd:Q8001708 wd:Q604444 wd:Q6815474 wd:Q622664 wd:Q5034686 wd:Q7191520 wd:Q1047060 wd:Q3344269 wd:Q1061104 wd:Q7894830
p:P4844
wds:Q65383876-FB05FED1-55C4-434F-8BA3-5D8534744863 wds:Q65383876-EE4DFDC6-2C57-47A0-AEBB-C36CC84DEED1 wds:Q65383876-48F127D2-19CB-4F99-AA94-F5917E83F07B wds:Q65383876-4ADEDA37-919D-410E-A885-A0B544E54052 wds:Q65383876-6CE492DE-E861-4CD8-A8DC-A89B8226EEAC wds:Q65383876-74334641-105C-4BD8-AEF8-56941033B593
wdt:P4844
wd:Q408524 wd:Q29004943 wd:Q423762 wd:Q413299 wd:Q18936 wd:Q50429626
p:P2899
wds:Q65383876-F0E2A999-80C4-4824-B202-6F0F33533D71
wdt:P2899
18
p:P1132
wds:Q65383876-239DAB1A-2458-47AA-AEFD-07F068D230D6
wdt:P1132
4890
p:P767
wds:Q65383876-1C77060B-C81D-400E-A510-78E6AFE38679
wdt:P767
wd:Q7054727
p:P8363
wds:Q65383876-5FEEB07F-EE57-4D18-8626-BD494D38C3F1
wdt:P8363
wd:Q78089383
p:P3098
wds:Q65383876-B5D3B39D-C51B-4D61-8B7A-8BB9E873CEF6
wdt:P3098
NCT00433511
p:P6099
wds:Q65383876-43BA7CDE-2B32-4FF5-AD55-70147132D326
wdt:P6099
wd:Q42824827